Prevalence of homologous recombination deficiency among all tumor types.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.1502
Abstract: 1502Background: Triple negative breast and ovarian cancer are known to have a high frequency of homologous recombination deficiencies (HRDef). The prevalence of HRDef among all tumors is unknown. Methods: Molecular profiles of 48,733 tumors obtained… read more here.
Keywords: prevalence homologous; homologous recombination; among tumor; deficiency among ... See more keywords